The optimal use of PEG-asparaginase in relapsed ALL--lessons from the ALLR3 Clinical Trial

Thumbnail
Fulltext:
137042.pdf
Size:
361.5Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2014
Author(s)
Masurekar, A.
Fong, C.
Hussein, A.
Revesz, T.
Hoogerbrugge, P.M.
Love, S.
Ciria, C.
Parker, C.
Krishnan, S.
Saha, V.
Source
Blood Cancer Journal, 4, (2014), pp. e203
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/137042   https://hdl.handle.net/2066/137042
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.